In Alzheimer's disease, 6-month treatment with GLP-1 analog prevents decline of brain glucose metabolism: Randomized, placebo-controlled, double-blind clinical trial

Michael Gejl, Albert Gjedde, Lærke Egefjord, Arne Møller, Søren B. Hansen, Kim Vang, Anders Rodell, Hans Brændgaard, Hanne Gottrup, Anna C. Schacht, Niels Møller, Birgitte Brock, Jørgen Rungby*

*Corresponding author for this work
157 Citations (Scopus)
115 Downloads (Pure)

Fingerprint

Dive into the research topics of 'In Alzheimer's disease, 6-month treatment with GLP-1 analog prevents decline of brain glucose metabolism: Randomized, placebo-controlled, double-blind clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences